Wellpartner Introduces AccessConvergence™
Newest offering combines contract pharmacy services and specialty pharmacy to expand 340B savings.
NEW YORK and PORTLAND, Ore., Feb. 2, 2015 /PRNewswire/ -- Wellpartner, Inc. is pleased to announce the addition of AccessConvergenceTM to its suite of 340B program services. AccessConvergence enables clients to greatly enhance their 340B programs by gaining access to previously "locked-away" specialty pharmaceutical prescriptions.
Historically, health plans and their pharmacy benefit managers have insisted that specialty prescriptions be filled in the pharmacy benefit manager's specialty pharmacies, rendering them unavailable for inclusion in a 340B program. "Covered entities and health plans understand the value of enabling the inclusion of these prescriptions in a 340B program; however, they lacked a mechanism to do so," said James Love, CEO of Wellpartner.
AccessConvergence, http://www.wellpartner.com/services/accessconvergence/, solves this problem by combining Wellpartner's proven contract pharmacy administration service, 340B AccessTM, with its nationally licensed URAC, ACHC and VIPPS accredited specialty pharmacy service, 340B AccessSpecialtyTM. In effect, Wellpartner serves as both a contract pharmacy administrator and a network specialty pharmacy.
AccessConvergence gives covered entities the ability to enhance their 340B programs and stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services.
Wellpartner is a Pinnacle Corporate Sponsor of Safety Net Hospitals for Pharmaceutical Access (SNHPA) and an exhibitor at the 340B Coalition Winter Conference in San Francisco February 4-6, 2015, where the company will be speaking about AccessConvergenceTM, other core products and services including a client reporting service, AccessIntegraTM and a data-driven audit support service called AccessCompareTM.
About Wellpartner
Wellpartner is a leading provider of 340B contract pharmacy programs for a wide variety of safety net hospitals and clinics. And, through our nationally licensed URAC, ACHC and VIPPS accredited specialty pharmacy, Wellpartner dispenses pharmaceuticals to selected patients of these hospitals and clinics. 340B AccessTM is a 100% outsourced solution for covered entities seeking a 340B contract pharmacy program. This product provides "gold standard" 340B eligibility methodologies, flexible data interfaces, customized pharmacy networks, inventory management and financial reconciliation, as well as a state-of-the-art reporting and analytics tool, AccessIntegraTM. Today, more than 100 covered entities trust 340B AccessTM.
340B AccessSpecialtyTM is Wellpartner's nationally licensed URAC, ACHC and VIPPS accredited specialty pharmacy program for covered entities and their patients. The pharmacy is included in a rapidly increasing number of health plans' specialty pharmacy networks. The high-touch/high service pharmacy was specifically designed to keep patient relationships where they belong – at the covered entity. As such, it is dedicated to working with a covered entity's entire provider team in the way that works best for them. Visit www.wellpartner.com for more information.
Contact:
Wellpartner, Inc.
Julee Whalin, 212.547.5088
[email protected]
SOURCE Wellpartner, Inc.
Share this article